| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2726573 | Seminars in Radiation Oncology | 2016 | 12 Pages |
Abstract
Standard management of early stage and advanced breast cancer has been improved over the past few years by knowledge gained about the biology of the disease, results from a number of eagerly anticipated clinical trials and the development of novel agents that offer our patients options for improved outcomes or reduced toxicity or both. This review highlights recent major developments affecting the systemic therapy of breast cancer, broken down by clinically relevant patient subgroups and disease stage, and briefly discusses some of the ongoing controversies in the treatment of breast cancer and promising therapies on the horizon.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sabrina Witherby, Tina Rizack, Bachir J. Sakr, Robert D. Legare, William M. Sikov,